Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award

Prof. Dr. Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award 

Prof. Dr. Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award | Physician | The Lower Danube University | Romania

Prof. Dr. Gabriela Gurău is an accomplished Romanian medical researcher, clinician, and academic leader with extensive contributions to the fields of clinical laboratory medicine, infectious diseases, and metabolic disorders. She holds a Ph.D. in Medical Sciences from the University of Medicine and Pharmacy “Carol Davila,” Bucharest, complemented by advanced certifications in diabetes, nutrition, metabolic diseases, and laboratory medicine from the Ministry of Health and the Training Center for Doctors and Pharmacists. Currently serving as Professor Habil. at the Faculty of Medicine and Pharmacy, University “Dunarea de Jos” of Galați, she also fulfills the role of Head of the Clinical Laboratory at the Clinical Emergency Hospital for Children “Sfântul Ioan.” Throughout her professional journey, Prof. Dr. Gabriela Gurău has demonstrated exceptional skill in integrating clinical diagnostics with translational research, focusing on pediatric infections, antibiotic resistance, microbiological profiling, and metabolic disorders. Her research interests include pathogen surveillance, microbial resistance mechanisms, pediatric metabolic health, and the interplay between microbiota and systemic diseases. With an active research portfolio, she has participated in numerous national and international projects, including innovative studies funded by PN II, AUF, and institutional grants, contributing significantly to Romania’s biomedical research landscape. She is the author and co-author of impactful peer-reviewed articles published in leading scientific journals indexed in Scopus and Web of Science, such as Life, Viruses, International Journal of Molecular Sciences, Applied Sciences, and Infection and Drug Resistance, reflecting her commitment to scientific excellence and knowledge dissemination. Her strong research skills span molecular diagnostics, laboratory analytics, data interpretation, and interdisciplinary collaboration, all of which reinforce her as a versatile scientist bridging clinical medicine and public health research. Recognized for her scholarly achievements and leadership, Prof. Dr. Gabriela Gurău has been a key figure in organizing medical conferences like MedFarmLab, served as Head of the Department of Morphological and Functional Sciences, and contributed actively to professional societies and research committees. Her dedication has earned her respect as a mentor, educator, and innovator in Romanian academia. Prof. Dr. Gabriela Gurău’s career exemplifies a synthesis of scientific rigor, community service, and academic distinction, underpinned by her mission to improve pediatric healthcare outcomes through evidence-based research. With her established reputation, international collaborations, and evolving leadership roles, Prof. Dr. Gabriela Gurău continues to advance the frontiers of laboratory medicine and inspire emerging generations of biomedical scientists worldwide.

Profile: Scopus | ORCID | Google Scholar

Featured Publications 

  1. Matache, E. R., Gurău, G., Stoian, V. I., Zaharia, A. E., Ciocoiu, M., Maftei, N. M., & Tutunaru, D. (2025). Bordetella pertussis in children: A retrospective analysis of the clinical impact and the role of vaccination. Life, 15(10), 1514.

  2. Matache, E. R., Gurău, G., Raileanu, C. R., Zaharescu, A., Popa, G. V., Maftei, N. M., & Tutunaru, D. (2025). Pathogen profile of children hospitalised with viral respiratory infections in Galati County, Romania. Viruses, 17(4), 586.

  3. Ursu, M., Cretu-Stuparu, M., Gurău, G., Nitoi, L. C., Nechita, A., & Arbune, M. (2024). An epidemiological perspective on new pediatric cases of type 1 diabetes and vitamin D deficiency in South-East Romania: A retrospective study. Children, 11(10), 1162.

  4. Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculet, E., Bujoreanu, F. C., & Tatu, A. L. (2024). An eastern county from a European eastern country—The characteristics of cutaneous microbiome in psoriasis patients—Preliminary results. Life, 14(6), 678.

  5. Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculet, E., Bujoreanu, F. C., & Popa, L. G. (2024). Comparative analysis of the cutaneous microbiome in psoriasis patients and healthy individuals—Insights into microbial dysbiosis: Final results. International Journal of Molecular Sciences, 25(19), 10583.

  6. Iancu, A. V., Arbune, M., Zaharia, E. A., Tutunaru, D., Maftei, N. M., Peptine, L. D., Tocu, G., & Gurău, G. (2023). Prevalence and antibiotic resistance of Enterococcus spp.: A retrospective study in hospitals of Southeast Romania. Applied Sciences, 13(6), 3866.

  7. Arbune, M., Gurău, G., Niculet, E., Iancu, A. V., Lupasteanu, G., Fotea, S., Vasile, M. C., & Tatu, A. L. (2021). Prevalence of antibiotic resistance of ESKAPE pathogens over five years in an infectious diseases hospital from South-East Romania. Infection and Drug Resistance, 14, 2369–2378.

 

Mar Jimenez de la Pena | Medicine and Health Sciences | Medical Hypothesis Award

Assoc. Prof. Dr. Mar Jimenez de la Pena | Medicine and Health Sciences | Medical Hypothesis Award

Assoc. Prof. Dr. Mar Jimenez de la Pena | Medicine and Health Sciences | Medical Hypothesis Award | Radiologist | University Hospital Quironsalud Madrid | Spain 

Assoc. Prof. Dr. Mar Jimenez de la Pena is a highly accomplished radiologist and academician with a distinguished career devoted to advancing diagnostic imaging, neuroimaging, and translational radiology. She completed her Licentiate in Medicine and Surgery at the Universidad Complutense de Madrid and specialized in Radiodiagnosis at Hospital 12 de Octubre in Madrid, establishing a robust clinical and scientific foundation. Currently serving as the Associate Head of Diagnostic Imaging at Hospital Universitario QuirónSalud Madrid, she also contributes as a Professor of Medicine at the Universidad Europea de Madrid, where she mentors medical students and radiology residents. Her professional experience spans more than two decades, encompassing academic instruction, clinical excellence, and leadership in medical imaging. Assoc. Prof. Dr. Mar Jimenez de la Pena has been actively engaged in national and international research collaborations, focusing on the application of advanced MRI techniques in neurological disorders, pediatric neuroimaging, and genetic syndromes. Her research interests center on neurodevelopmental disorders, brain perfusion analysis, and the application of artificial intelligence in MRI interpretation. She has demonstrated outstanding research skills in multimodal MRI data acquisition, neuroimage analysis, and clinical study design. Her work has been published in top-tier journals such as Frontiers in Neuroscience, Neuroradiology, European Journal of Medical Genetics, and American Journal of Medical Genetics Part A, significantly contributing to the understanding of complex neuroimaging patterns and clinical correlations. With over 40 peer-reviewed articles, including 33 international papers, and multiple book chapters, she has established a strong academic footprint. Assoc. Prof. Dr. Mar Jimenez de la Pena has received over 30 prestigious awards, including 29 honors from the Spanish Society of Radiology (SERAM), recognition from the Spanish Society of Neurosurgery (SENR), and an American Society of Radiology Award for her scientific presentations. Her memberships in SERAM, SENR, and ESR, alongside her role as a reviewer for Radiología, underscore her professional dedication to the advancement of radiological science. A visionary researcher and educator, she continues to contribute to training programs for medical imaging professionals, fostering innovation and excellence in radiological education. In conclusion, Assoc. Prof. Dr. Mar Jimenez de la Pena exemplifies a perfect blend of clinical expertise, academic leadership, and research innovation, making her a highly deserving candidate for international recognition in medical imaging and radiological research. Her continued contributions promise to shape the future of neuroimaging and radiodiagnostic excellence globally.

Profile: ORCID

Featured Publications 

  1. Jimenez de la Pena, M. (2023). Tatton‐Brown–Rahman syndrome: Novel pathogenic variants and new neuroimaging findings. American Journal of Medical Genetics Part A. Citations: 12

  2. Jimenez de la Pena, M. (2023). White-matter lesions and cortical cerebral blood flow evaluation by 3D arterial spin-labeled perfusion MRI in asymptomatic divers: Correlation with patent foramen ovale occurrence. Journal of Clinical Medicine. Citations: 18

  3. Jimenez de la Pena, M. (2022). Development of a super-resolution scheme for pediatric magnetic resonance brain imaging through convolutional neural networks. Frontiers in Neuroscience. Citations: 25

  4. Jimenez de la Pena, M. (2022). Mutations in the COL18A1 gene associated with Knobloch syndrome and structural brain anomalies: A novel case report and literature review of neuroimaging findings. Neurocase. Citations: 9

  5. Jimenez de la Pena, M. (2021). Neuroimaging findings in patients with EBF3 mutations: Report of two cases. Molecular Syndromology. Citations: 7

  6. Jimenez de la Pena, M. (2021). Abnormal frontal gyrification pattern and uncinate development in patients with KBG syndrome caused by ANKRD11 aberrations. European Journal of Paediatric Neurology. Citations: 15

  7. Jimenez de la Pena, M. (2020). Automatic identification of atypical clinical fMRI results. Neuroradiology. Citations: 22

 

Christina Pettan-Brewer | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr . Christina Pettan-Brewer | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr. Christina Pettan-Brewer | Medicine and Health Sciences | Associate Professor and Director | School of Medicine University of Washington | United States

Associate Professor Dr. Christina Pettan-Brewer is a distinguished veterinary scientist and global health leader whose career bridges research, education, and international policy. With advanced training in veterinary medicine, genetics, epidemiology, and One Health, she has contributed significantly to understanding zoonotic diseases, environmental health, and the genetic and molecular mechanisms of aging and disease. She serves as a key advisor and expert for international organizations including UNEP Nature for Health, WHO, PREZODE, and the International Alliance against Health Risks in Wildlife Trade, demonstrating her influence on global health strategies and pandemic prevention platforms. As Senior Editor of CABI One Health and Editor-in-Chief of Beyond One Ocean Health, she plays a pivotal role in advancing interdisciplinary scientific communication. Multilingual and internationally engaged, she combines her academic role at the University of Washington with mentorship, Fulbright program leadership, and advocacy for underrepresented groups in science, making her a recognized authority in One Health, planetary health, and global public health innovation.

Professional Profile 

Education  

Associate Professor Dr. Christina Pettan-Brewer has a strong and diverse educational background that reflects her interdisciplinary expertise. She began her academic journey in Brazil, earning a technical degree in Zoology and Clinical Pathology, followed by a Doctor of Veterinary Medicine with honors from the Universidade Federal de Viçosa. She then pursued advanced studies in the United States at the University of California, Davis, completing a Master of Science in Wildlife and Zoological Medicine and Comparative Pathology while also receiving accreditation as a Doctor of Veterinary Medicine. To further strengthen her expertise in global health, she obtained a PhD in One Health and Global Health from the Federal University of Paraná in collaboration with the University of Colorado, specializing in Indigenous Health and Emerging Infectious Diseases. Her educational achievements, marked by honors and top performance, form the foundation of her career in veterinary medicine, public health, genetics, and planetary health.

Professional Experience

Associate Professor Dr. Christina Pettan-Brewer has built an impressive professional career that integrates academic leadership, research, and international advisory roles. She began her faculty journey as an Assistant Professor at Centenary University in New Jersey, where she developed curricula for pre-veterinary and pre-medicine programs while conducting research on avian pathology during the West Nile Virus outbreak. At the University of Washington School of Medicine, she has advanced through roles as Acting Instructor, Acting Assistant Professor, and now Associate Professor in the Department of Comparative Medicine, contributing extensively to research in genetics, zoonotic diseases, and One Health. Beyond academia, she has served as a senior advisor and technical expert for global organizations such as UNEP, WHO, PREZODE, and international veterinary associations, shaping global health strategies and pandemic preparedness. Her editorial leadership with CABI One Health and Beyond One Ocean Health further demonstrates her influence in scientific communication, while her Fulbright program advisory role highlights her dedication to mentoring and international academic exchange.

Research Interest

Associate Professor Dr. Christina Pettan-Brewer’s research interests lie at the intersection of veterinary medicine, public health, and planetary health, with a strong emphasis on the One Health approach. She focuses on zoonotic and emerging infectious diseases, pandemic prevention, and the interconnectedness of human, animal, and environmental health. Her work extends to the genetic and molecular mechanisms of aging, chronic diseases, and susceptibility to toxins, as well as the health impacts of climate change and biodiversity loss. She is particularly interested in Indigenous health, global health equity, and the role of wildlife and ecosystem preservation in preventing future pandemics. Through her interdisciplinary research, she seeks to advance collaborative solutions that strengthen global health systems, protect vulnerable populations, and promote sustainable, resilient communities

Award and Honor

Associate Professor Dr. Christina Pettan-Brewer has been recognized with numerous honors and prestigious appointments that highlight her global leadership in One Health and public health. She has served as a United Nations Environment Programme (UNEP) One Health Expert and Technical Advisory Group member for the Nature for Health initiative, representing Latin America and later co-chairing its expert committee. Her expertise has been sought by the World Health Organization’s Global Preparedness Monitoring Board, PREZODE’s International Data Working Group, and the Agence Nationale de la Recherche in France for evaluating pandemic prevention strategies. She has also been appointed as a Fulbright Program Adviser, National Scholar Program Ambassador, and Reviewer, reflecting her commitment to international education and research exchange. In addition, her editorial leadership roles as Senior Editor of CABI One Health and Editor-in-Chief of Beyond One Ocean Health stand as significant honors that demonstrate her influence in shaping global scientific dialogue. These achievements collectively underscore her distinguished reputation as a trusted advisor, scholar, and thought leader in global health.

Publications Top Noted

Effects of Covid-19 Pandemic in the Surveillance and Control of Neglected Tropical Diseases and Malaria: A Systematic Review

Year: 2025

Protecting Urban Wildlife Fauna, Fighting Zoonoses, and Preventing Biophobia in Brazil

Year: 2025

Conclusion

Dr. Christina Pettan-Brewer is a highly suitable candidate for the Best Researcher Award. Her career exemplifies global leadership, interdisciplinary research, and a strong commitment to advancing One Health, pandemic prevention, and planetary health. With a proven record of academic excellence, international collaboration, and impactful advisory roles, she stands out as a researcher whose work bridges science, policy, and education. Addressing minor improvements related to visibility of individual research outputs would further strengthen her profile, but her broad and meaningful contributions make her a compelling and deserving nominee for this recognition.

 

Jian Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Jian Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Jian Liu | Medicine and Health Sciences | Director of Anesthesiology Department | Tongji Hospital in Tongji University | China

Prof. Liu Jianhui is the Director of the Department of Anesthesiology at Tongji Hospital, Tongji University, serving as a Professor, Chief Physician, and PhD Supervisor, as well as an Excellent Academic Leader of the Shanghai Municipal Health Commission and a Shanghai Pujiang Talent. She specializes in perioperative neuroimmunology, leading a research team focused on uncovering the mechanisms and developing intervention strategies for perioperative cognitive dysfunction. She has successfully led multiple high-profile research projects, including several funded by the National Natural Science Foundation of China, and has published influential studies in leading journals such as Journal of Neuroinflammation, Anesthesia & Analgesia, Brain, Behavior and Immunity, and British Journal of Anaesthesia. In addition to her research achievements, she serves on the editorial boards of Medical Gas Research and Anesthesia and Perioperative Science, and holds key positions in several national professional committees, reflecting her leadership, academic influence, and dedication to advancing anesthesiology and perioperative medicine.

Professional Profile 

Education  

Prof. Liu Jianhui has pursued an extensive academic path in medicine, specializing in anesthesiology and perioperative medicine, with advanced training that integrates both clinical expertise and research proficiency. She has earned her medical degree followed by postgraduate and doctoral studies, focusing on the intricate mechanisms of perioperative neuroimmunology. Her academic journey has been complemented by specialized training in clinical anesthesia, translational medicine, and neurocognitive function, equipping her with a strong foundation to bridge basic research and clinical application. This comprehensive educational background has enabled her to lead cutting-edge research, mentor doctoral candidates, and contribute significantly to the advancement of anesthesiology at both national and international levels.

Professional Experience

Prof. Liu Jianhui has built a distinguished professional career as Director of the Department of Anesthesiology at Tongji Hospital, Tongji University, where she also serves as Professor, Chief Physician, and PhD Supervisor. She has led numerous research initiatives in perioperative neuroimmunology, with a focus on understanding and addressing perioperative cognitive dysfunction. Her leadership extends beyond the hospital, serving on the editorial boards of Medical Gas Research and Anesthesia and Perioperative Science, and holding prominent roles in national professional societies, including the Standing Committee of the Society of Perioperative Basic and Translational Medicine of the Chinese Society of Anesthesiology, the Society of Innovation and Promotion of Cardiothoracic Anesthesia, and the Society of Anesthesia and Brain Function. Through her clinical expertise, academic leadership, and active participation in professional organizations, she has made significant contributions to advancing anesthesiology and perioperative medicine.

Research Interest

Prof. Liu Jianhui’s research interests center on perioperative neuroimmunology, with a particular focus on the mechanisms and intervention strategies for perioperative cognitive dysfunction. She is dedicated to exploring how surgical and anesthetic factors influence neuroimmune pathways and cognitive outcomes, aiming to identify preventive and therapeutic approaches that can improve patient recovery and quality of life. Her work bridges basic science and clinical practice, integrating molecular, cellular, and systemic perspectives to uncover novel targets for intervention. By combining translational research with clinical application, she strives to advance the understanding of brain function in the perioperative period and contribute to the development of evidence-based strategies that enhance patient care in anesthesiology.

Award and Honor

Prof. Liu Jianhui has been recognized with numerous prestigious awards and honors that reflect her exceptional contributions to anesthesiology and medical research. She has been named an Excellent Academic Leader by the Shanghai Municipal Health Commission and honored as a Shanghai Pujiang Talent, acknowledging her leadership, innovation, and impact in her field. Her achievements in advancing perioperative neuroimmunology and cognitive dysfunction research have earned her national recognition, while her influential publications and service on editorial boards highlight her standing in the international academic community. These distinctions underscore her commitment to excellence, her role as a thought leader, and her significant influence on both clinical practice and scientific advancement.

Publications Top Noted

Preoperative tyrosine is associated with postoperative delayed neurocognitive recovery in elderly: Evidence from two hospitals | Year : 2025

Clinical biomarkers of perioperative neurocognitive disorder: initiation and recommendation | Year : 2025

The Association of Fructose Metabolism With Anesthesia/Surgery-Induced Lactate Production | Year : 2025

Conclusion

Prof. Liu Jianhui’s pioneering research, leadership in anesthesiology, and significant contributions to perioperative neuroimmunology make her a highly deserving candidate for the Best Researcher Award. Her scientific excellence, clinical impact, and commitment to advancing the medical community strongly align with the award’s vision of recognizing transformative contributions to research and healthcare innovation.

Admasu Gizaw | Medicine and Health Sciences | Best Researcher Award

Admasu Gizaw | Medicine and Health Sciences | Best Researcher Award

Mr Admasu Gizaw, Jimma University, Ethiopia

Admasu Gizaw, MScN, Ph.D. Fellow🎓🩺 is an esteemed nursing educator and researcher at Jimma University, Ethiopia. With an MSc in Adult Health Nursing (2010) and currently pursuing a Ph.D. in Nursing, his research focuses on patient-centered care and nursing standards. He has over 14 years of experience, serving as a lecturer, CPD officer, and program coordinator. His expertise spans mentorship, curriculum development, and systematic reviews. A dedicated contributor to national nursing policies, he has authored impactful studies on public health and nursing practice. Proficient in statistical software 📊, he actively advances Ethiopia’s healthcare education and nursing profession. 🚑📚

Publication Profile

Scopus

Education

Admasu Gizaw 🎓 is an experienced nursing professional specializing in Adult Health Nursing (Medical-Surgical Nursing). He earned his MScN from Jimma University in 2010, focusing on nurses’ intention to stay in the profession 🏥. Currently, he is a Ph.D. Fellow in Nursing at Jimma University (since 2023), researching person-centered nursing care and its outcomes in Ethiopian university hospitals 💡. His journey began with a BScN in Nursing from Jimma University (2004-2006) 🩺. With a strong academic and research background, he is dedicated to improving nursing care and fostering better healthcare environments in Ethiopia 🌍.

Experience

Admasu Gizaw is a dedicated nursing professional with extensive experience in surgical and academic settings 🏥👨‍⚕️. He began his career as a staff nurse in the operating theatre (2003-2004 E.C) before advancing to head nurse (2004-2005 E.C) and later serving as Vice Nursing Service Director at JUMC (2007-2008 E.C) 🌟. He also worked as Delegate Nursing Service Director (Dec-June 2008 E.C). With over nine years as a lecturer and Assistant Professor at Jimma University (since May 2016) 🎓, he coordinated the Operation Theatre Nursing Specialty Program (2017-2020) and currently serves as CPD Officer at Jimma University Institute of Health (since Feb 2023) 📚.

Certificate Awarded Training

Mr. Admasu Gizaw has made significant contributions to the nursing field in Ethiopia, particularly in course development and training. Notably, he has developed and trained courses on Safe Operation Theatre, Nursing Documentation and Reporting, Wound Care, Body Fluid Management, and Nursing Process Application for organizations like Jimma University, Ethiopian Nurses Association, and the Ministry of Health. His work includes the preparation of national nursing standards, undergraduate program guidelines, and licensure examination blueprints. Mr. Gizaw has also been involved in the development of nursing curricula and earned certificates of contribution and recognition from various prestigious institutions. 🎓🩺📚🇪🇹

Research Focus

Admasu Gizaw’s research primarily focuses on public health issues, particularly in low-resource settings. His studies examine global and regional health burdens, with specific attention to allergic disorders, meningitis, reproductive health, and chronic conditions like hypertension. He has contributed significantly to understanding the risk factors and prevalence of various diseases, including cancer and labor induction. His work also delves into the predictors of moral distress among healthcare workers and factors affecting health service utilization, especially in Ethiopian populations. Gizaw’s research aims to improve healthcare delivery and policy through evidence-based insights. 📊🌍🩺💉

Publication Top Notes

Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019

Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Predictors of Induction of Labor and Success Rate Among Mothers Giving Birth at Jimma University Medical Centre South West Ethiopia: Unmatched Case Control Study

Lifestyle modification practices and associated factors among hypertensive patients at Gambella Hospital Southwest Ethiopia; 2019

Predictors of moral distress among nurses working in Jimma University Medical Center, South West Ethiopia

Cancer Warning Symptoms Awareness and Associated Factors Among Individuals Living in Assella Town, Ethiopia

Reproductive health service utilization and associated factors among adolescents at public school in Adama Town east Shewa Ethiopia, 2018

 

Tracey Young-Sharma | Medicine and Health Sciences | Best Researcher Award

Tracey Young-Sharma | Medicine and Health Sciences | Best Researcher Award

Dr Tracey Young-Sharma, Ministry of Health and Medical Service FIji, Fiji

Dr. Tracey Young-Sharma is an accomplished physician specializing in internal medicine and antimicrobial resistance (AMR). She holds a Masters of Medicine from Fiji National University (2019) and has been awarded the ASID GOLD Medal. Currently an AMR consultant for the World Health Organization, Dr. Young-Sharma has held various roles, including Consultant Physician and Registrar at CWM Hospital. She has contributed to multiple studies on antimicrobial resistance and its impact in Fiji, with notable publications in The Lancet and JGAR. Dr. Young-Sharma is also the Chairperson of the Infection Prevention Control Committee at CWMH. 🏥🦠📚🌍

Publication Profile

Scopus

Education

Dr. Tracey Young-Sharma is a highly accomplished medical professional with a strong background in Internal Medicine. She completed her Masters of Medicine in Internal Medicine at Fiji National University in 2019. Prior to that, she earned a Postgraduate Diploma in Internal Medicine in 2016 and a Bachelor’s degree in Medicine and Surgery from the Fiji School of Medicine in 2010. Dr. Young-Sharma has been recognized for her excellence in the field, receiving the prestigious Australian Society of Infectious Disease (ASID) GOLD Medal Award 🏅💉. Her dedication to improving healthcare continues to inspire and impact the medical community. 👩‍⚕️🌟

Experience

Dr. Tracey Young-Sharma is an AMR consultant for the World Health Organisation (WHO) since August 2024 🌍. Previously, she served as a Consultant Physician at CWM Hospital (2022-2024) 🏥 and as a Registrar at the same hospital from 2016 to 2021. Prior to that, she worked as a Registrar in Internal Medicine at Labasa Hospital in 2015 🩺. Dr. Young-Sharma began her career as a Medical Officer at Levuka Hospital and Koro Health Centre (2012-2014) 🏥 and completed her internship at CWM Hospital in 2011. Her extensive experience spans various medical roles, contributing to healthcare development. 👩‍⚕️🌿

Professional Memberships 

Dr. Tracey Young-Sharma is a dedicated healthcare professional with strong affiliations in the medical field. She is an Associate Member of the Internal Medicine Society of Australia and New Zealand and a member of the Internal Medicine Organisation of the Pacific. Additionally, Dr. Young-Sharma is part of the International Women’s Association, the Fiji Medical Association, and the Australasian College of Infection Prevention and Control. In 2022, she served as the Chairperson of the Infection Prevention and Control Committee at CWMH. Her active roles reflect her commitment to advancing healthcare and fostering collaboration in the medical community. 🌍👩‍⚕️💉🩺

Research Focus

Dr. Tracey Young-Sharma’s research primarily focuses on antimicrobial resistance (AMR), particularly in resource-limited settings like Fiji. Her work involves genomic surveillance and epidemiological studies to understand the spread of carbapenem-resistant organisms and other multidrug-resistant pathogens. Dr. Young-Sharma’s studies also emphasize the impact of AMR on healthcare outcomes, including attributable mortality and length of hospital stays. She is also involved in improving healthcare workers’ knowledge and readiness to combat AMR through intervention studies. Her research aims to inform public health strategies and healthcare policies in the context of global AMR challenges. 🦠🔬🌍👩‍🔬💉

Publication Top Notes

Successful management of a multi-species outbreak of carbapenem-resistant organisms in Fiji: a prospective genomics-enhanced investigation and response

Knowledge, attitudes, and readiness about critical antimicrobial resistant organisms among healthcare workers at colonial war memorial hospital in Fiji: a pre and post intervention study

The epidemiology of enterococci in a tertiary hospital and primary healthcare facilities in Fiji (2019–2022)

The changing epidemiology of antimicrobial resistance in Fiji: a descriptive analysis of antimicrobial susceptibility and trends of endemic and emerging pathogens, 2019–2022

Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji

Epidemiology, antimicrobial resistance and outcomes of Staphylococcus aureus bacteraemia in a tertiary hospital in Fiji: A prospective cohort study

Panagiotis Liakos | Medicine and Health Sciences | Best Researcher Award

Panagiotis Liakos | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Panagiotis Liakos, Faculty of Medicine, University of Thessaly, Greece

Prof. Dr. Panagiotis Liakos is an esteemed biochemist and researcher specializing in cellular biochemistry and hypoxia-related cancer mechanisms. He earned his Maîtrise, Master’s, and Ph.D. in Molecular and Cellular Biology from Joseph Fourier I University, France. His postdoctoral work at Aristotle University in Greece laid the foundation for his academic career, leading him to his current role as Professor and Director of the Department of Basic and Applied Biomedical Sciences at the University of Thessaly. His research focuses on hypoxia-inducible factors (HIFs), particularly HIF-2α, exploring its role in cancer and angiogenesis. 🧬👨‍🔬📚

Publication Profile

google scholar

Education 

Prof. Dr. Panagiotis Liakos is a distinguished biochemist with a career spanning from Grenoble to Greece. He completed a Maîtrise in Biochemistry (1994) and a Master’s in Molecular and Cellular Biology (1995) at Joseph Fourier I University, France, followed by a PhD (1999) in Biochemistry and Cellular Endocrine Regulation. His postdoctoral research was conducted at Aristotle University Thessaloniki. In 2003, he became a Lecturer at the University of Thessaly, advancing to Professor in 2022. Currently, he leads the Department of Basic and Applied Biomedical Sciences. His clinical expertise includes years at Larissa University Hospital. 🌍🔬📚👨‍🔬💼

Research Project

Prof. Dr. Panagiotis Liakos has significantly contributed to pioneering health research. Highlights include leading the French Ministry of Health’s 1994 Breast Cancer Prevention program, advancing studies on ACTH receptor expression in adrenal glands (1995-1998), and collaborating on a French-Portuguese program to analyze steroidogenic enzymes in rats and adrenal carcinomas. Furthering adrenal cancer research, he partnered with the Fondation pour la Recherche Médicale (1998-1999). Dr. Liakos explored metalloproteases in skin pathophysiology in a Greek program (2001-2003) and obesity rates in Thessaly (2005-06). His work on signaling pathways under hypoxic stress enriches endocrine research. 🧬🔬

Experience

Prof. Dr. Panagiotis Liakos has been a dedicated educator and coordinator in molecular biology, genetics, and biochemistry since 2001. He taught Biochemistry I & II and Clinical Biochemistry at Democritus University of Thrace, later joining the University of Thessaly to instruct Molecular Biology, Metabolism Regulation, and various biochemistry courses. Since 2004, he has led the Clinical Biochemistry course for medical students and coordinated the Cellular Signaling course in molecular medicine. His teaching repertoire includes postgraduate courses on reproduction genetics, human genetics, and balanced nutrition. Prof. Liakos’s commitment to education spans two decades, fostering expertise in health sciences. 📘🧬👨‍🏫✨

Honors

Prof. Dr. Panagiotis Liakos has been recognized internationally for his research achievements, receiving prestigious scholarships and fellowships from the French Ministry of Research and Fondation pour la Recherche Médicale. These honors underscore his dedication and impactful contributions to his field, highlighting the global relevance of his work. Through these awards, Dr. Liakos has advanced his research, fostering significant progress and collaboration. His achievements not only emphasize his scientific expertise but also reflect his commitment to excellence in research and innovation. 🌍📚🔬

Research Focus

Prof. Dr. Panagiotis Liakos specializes in cellular and molecular biology, particularly focusing on hypoxia and its effects on cellular processes. His research explores how hypoxia-inducible factors (HIFs), especially HIF-1 and HIF-2, regulate gene expression under low-oxygen conditions and influence cancer progression, lipid metabolism, and viral replication. Dr. Liakos’s work also examines the effects of oxidative stress and signaling pathways like PI-3K and MAPK on cellular adaptation to hypoxic stress. His contributions are significant in understanding hypoxia’s role in disease states such as cancer and liver disease, and its broader implications for therapeutic development. 🧬🩺🔬🌬️📊

Publication Top Notes

Hypoxia causes triglyceride accumulation by HIF-1-mediated stimulation of lipin 1 expression

Cobalt induces hypoxia-inducible factor-1α (HIF-1α) in HeLa cells by an iron-independent, but ROS-, PI-3K-and MAPK-dependent mechanism

Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells

The role of hypoxia‐inducible factor‐2 alpha in angiogenesis

Cushing’s syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis

Cobalt stimulates HIF-1-dependent but inhibits HIF-2-dependent gene expression in liver cancer cells

 

Antoinette Oot | Medicine and Health Sciences | Best Researcher Award

Antoinette Oot | Medicine and Health Sciences | Best Researcher Award

Dr Antoinette Oot, NYU / NYC HHC Bellevue, United States

Based on the information provided, Antoinette Oot, MD, MPH, appears to be a strong candidate for a Best Researcher Award.

Publication profile

Scopus

Education

Antoinette Oot, MD, MPH, has a robust educational background that spans several prestigious institutions. She is currently a Fellow in Complex Family Planning at New York University/NYC Health + Hospitals Bellevue, a role she has held since July 2024. Previously, she served as the Administrative Chief Resident in the Department of Obstetrics and Gynecology at the same institution from 2020 to 2024. Dr. Oot earned her M.D./M.P.H. with honors from Northwestern University, Feinberg School of Medicine in 2020, and holds a B.Sc. in Chemistry with Honors from Brown University. Her early academic journey began at New York University, where she studied biochemistry. This educational trajectory demonstrates her commitment to both clinical excellence and public health, making her a strong candidate for the Best Researcher Award.

Work Experience & Post-Graduate Learning

Dr. Oot has accumulated significant work experience and engaged in continuous post-graduate learning, particularly in leadership and educational roles. As the Administrative Chief Resident at NYU, she optimized personnel coverage, facilitated communication, and promoted a fair work environment. She also served as the Resident OB/Gyn Clerkship Advisor, providing mentorship and improving medical education. Additionally, Dr. Oot has been an advocate for resident perspectives as a Class Representative on the Education Committee at NYU Langone Hospitals. Her experience extends to mentoring students and contributing to curricular development at Northwestern University. These roles highlight her dedication to improving medical education and her leadership skills, reinforcing her suitability for the Best Researcher Award.

Honors/Awards

Dr. Oot has received numerous honors and awards throughout her career, reflecting her outstanding contributions to the field of obstetrics and gynecology as well as public health. Notable awards include the 2023 Ryan Program Resident Award for Excellence in Family Planning and the 2022 Resident Recognition Award for Medical Student Education from NYU OB/GYN. She also received the Excellence in Public Health Award from the US Public Health Services in 2020 and was elected to the Gold Humanism Honor Society in 2019. These accolades underscore her exceptional research, clinical skills, and commitment to advancing women’s health, making her an exemplary candidate for the Best Researcher Award.

Presentations

Dr. Oot has actively participated in academic presentations, sharing her research findings at national conferences. In 2023, she delivered an oral presentation at the American Public Health Association Annual Meeting on increasing HIV pre-exposure prophylaxis among cisgender women. Her poster presentations at the Society of Gynecologic Surgeons and Society of Maternal-Fetal Medicine annual meetings further highlight her research involvement in women’s health and obstetric care. Her ability to present complex medical research to her peers indicates her leadership in the field and further supports her candidacy for the Best Researcher Award.

Publications

Dr. Oot has an impressive list of publications, contributing to various high-impact journals in the fields of obstetrics, gynecology, and public health. Her research spans a range of topics, including maternal morbidity, HIV prevention, and vaginal health, showcasing her broad expertise and commitment to improving patient outcomes. Notably, her recent work includes a mixed-methods evaluation of an HIV pre-exposure prophylaxis educational intervention published in AIDS Care and studies on maternal health in the Journal of Women’s Health. Her extensive publication record is a testament to her research capabilities, making her a strong candidate for the Best Researcher Award.

Personal Interests

Outside of her professional life, Dr. Oot enjoys baking, needlepoint, embroidery, and attending comics and art festivals. These hobbies provide a well-rounded perspective to her character, balancing her rigorous academic and professional pursuits with creative and relaxing activities. This personal insight into Dr. Oot’s life adds to her overall profile, showing her as a dedicated and multifaceted individual, further strengthening her candidacy for the Best Researcher Award.

Conclusion

Dr. Antoinette Oot’s extensive education, leadership in medical education, significant research contributions, and numerous awards position her as an outstanding candidate for the Best Researcher Award. Her dedication to advancing women’s health and public health, coupled with her personal commitment to mentorship and education, make her a deserving recipient of this recognition.

Research focus

The research focus of this individual centers on women’s health, obstetrics, and gynecology, with a particular emphasis on conditions affecting women such as genitourinary syndrome of menopause, maternal morbidity, and bacterial vaginosis. They also explore healthcare practices and policies, including interventions for HIV prevention and the evaluation of healthcare delivery in obstetric settings. Additionally, they investigate the use of electronic health records for analyzing maternal and neonatal complications, reflecting a commitment to improving health outcomes for women through research and healthcare policy reform. 🌸👩‍⚕️📊💊

Publication top notes

A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause

A mixed-methods evaluation of an HIV pre-exposure prophylaxis educational intervention for healthcare providers in a NYC safety-net hospital-based obstetrics and gynecology clinic

Association of Antenatal Housing Instability with Perinatal Care Utilization and Outcomes

Vaginal and Extra-Vaginal Bacterial Colonization and Risk for Incident Bacterial Vaginosis in a Population of Women Who Have Sex with Men

Management of Pelvic Organ Prolapse in the Adult Congenital Genitourinary Patient

Trends and Risk Markers for Severe Maternal Morbidity and Other Obstetric Complications

Genetic variation in toll-like receptor 5 and colonization with flagellated bacterial vaginosis-associated bacteria

Using Electronic Health Record and Administrative Data to Analyze Maternal and Neonatal Delivery Complications

Today’s Students, Tomorrow’s Physicians: Opinions on Enacted and Prospective Health Care Policies

 

 

Rajendra Rohokale | Medicine and Health Sciences | Best Researcher Award

Rajendra Rohokale | Medicine and Health Sciences | Best Researcher Award

Dr Rajendra Rohokale, University of Florida, United States

Dr. Rajendra Rohokale is a Research Scientist at the University of Florida, specializing in Synthetic Organic Chemistry, Carbohydrate Chemistry, and Glycochemistry. With a Ph.D. from Savitribai Phule Pune University, his notable projects include synthesizing complex carbohydrates for therapeutic applications and developing fully synthetic cancer vaccines. Dr. Rohokale’s work has led to significant advancements in glycoimmunology and drug delivery. An experienced researcher and reviewer for prestigious journals, he has over 360 citations on Google Scholar and holds an Orchid ID: orcid.org/0000-0001-8083-0466. 🌟🧪🔬📚

Publication profile

Orcid

Education

🎓 From 2010 to 2017, Rajendra Rohokale pursued a Ph.D. in Organic Chemistry at the Department of Chemistry, Savitribai Phule Pune University, Pune, India, under the guidance of Prof. Dilip D. Dhavale (F.A.Sc, F.N.A.Sc.). Their thesis was titled “Chiron Approach Towards the Syntheses of Amino Acids, Piperidine, Azepane, Polyhydroxylated Pyrrolizidine Alkaloids and Activation of Diazo-Ketones Using Visible Light Photoredox Catalysis and Dye.” [Name] earned their Master of Science (Organic Chemistry) (First Class) from the same university in 2009 and completed their Bachelor of Science (Chemistry) (First Class with Distinction) from New Arts, Science, and Commerce College, Ahmednagar in 2007. 📚🔬

Experience

🧪 Since August 2023, I’ve been a Research Scientist at the University of Florida, Gainesville. From January 2019 to August 2023, I was a Post-doctoral Research Associate at the same institution. My work focuses on synthesizing complex carbohydrates and their conjugates for therapeutic applications, including the development of glycosphingolipids (GSLs) and monophosphoryl lipid-A derivatives as cancer vaccine carriers. I specialize in synthetic organic and carbohydrate chemistry, creating efficient methods for synthesizing oligosaccharides and glycoconjugates. My research aims to advance cancer immunotherapy and glycoimmunology, with significant contributions to medical science. 💊🧫🔬

Presentations

He have actively participated in numerous esteemed conferences, including the Florida Heterocyclic Conference 2022 (FloHet 2022) at the University of Florida in March 2022 and the ChemPhotoChem-EJOC joint virtual symposium on Photoreact Catalysis in December 2021. He also attended FloHet 2020 at the University of Florida in March 2020. He presented a talk at the National Conference on “Bioinspired Materials in Science” at New Arts College, Pune, India, in January 2018. Additionally, He participated in the Satellite Meeting on Frontiers in the Chemistry & Biology of Oligosaccharides in January 2014 and attended various other international conferences from 2009 to 2013. 🌟🔬🌍📚

Research focus

Dr. Rajendra Rohokale’s research focuses on the synthesis and functional analysis of glycosphingolipids (GSLs) and their interactions in cell membranes. His work spans developing bifunctional GSL probes for studying GSL-interacting proteins, creating novel vaccine adjuvants, and exploring bacterial polysaccharide-based antibacterial conjugate vaccines. He also delves into advanced chemical synthesis techniques for GSLs and their derivatives, utilizing methods like diastereoselective cycloaddition and chemoenzymatic synthesis. Dr. Rohokale’s contributions significantly impact medicinal chemistry, organic chemistry, and infectious disease research. 🧪🔬💉

Publication top notes

Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes

Diastereoselective 1,3-Dipolar Intramolecular Nitrone Olefin Cycloaddition (INOC) Reaction of a Sugar-derived Allyl Alcohol: Synthesis of Functionalized Aminocyclopentitols.

Monophosphoryl Lipid A-Rhamnose Conjugates as a New Class of Vaccine Adjuvants

Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines

Structural characterization and analysis of different epimers of neutral glycosphingolipid LcGg4 by ion mobility spectrometry-mass spectrometry

A Diversity-Oriented Strategy for Chemical Synthesis of Glycosphingolipids: Synthesis of Glycosphingolipid LcGg4 and Its Analogues and Derivatives

Iridium(III)-Catalyzed Alkynylation of 2-(Hetero)arylquinazolin-4-one Scaffolds via C–H Bond Activation

Eosin y photoredox catalyzed net redox neutral reaction for regiospecific annulation to 3-sulfonylindoles: Via anion oxidation of sodium sulfinate salts

Metal-Free Synthesis of 3-Thiocyanatobenzothiophenes by Eosin Y Photoredox-Catalyzed Cascade Radical Annulation of 2-Alkynylthioanisoles

Visible-Light-Mediated Eosin Y Photoredox-Catalyzed Vicinal Thioamination of Alkynes: Radical Cascade Annulation Strategy for 2-Substituted-3-sulfenylindoles

 

 

 

Gulali Aktas | Medicine and Health Sciences | Best Researcher Award

Gulali Aktas | Medicine and Health Sciences | Best Researcher Award

Prof Dr Gulali Aktas, Abant Izzet Baysal University Hospital, Turkey

Prof. Dr. Gulali Aktas is a dedicated physician with 24 years of experience in internal medicine. As an academician for 13 years, he has mentored countless medical students and contributed to significant research. He holds an MD and Associate Professorship from Abant Izzet Baysal University. His prolific work includes 183 international journal publications, 19 conference presentations, and 11 book chapters. Recognized for his excellence, he was nominated for the Raise the Line Faculty Award in 2022 and is listed in Stanford University’s top 2% scientists. Fluent in Turkish, English, and basic German, he champions patient-centered care and lifelong learning. 🏥📚🌟

Publication profile

google scholar

Education

Dr. Gulali Aktas is an Associate Professor of Internal Medicine since 2015. They completed their Internal Medicine residency (PhD equivalent) at Ondokuz Mayis University, Samsun, Turkey (2003-2008), and Pulmonology residency at Yedikule Training and Research Hospital, Istanbul, Turkey (2002-2003). They earned their MD from Ondokuz Mayis University in 2000. With 211 research contributions published in peer-reviewed journals and an impressive H-index of 35 (WoS), 42 (Google Scholar), and 36 (Scopus), Dr. Gulali Aktas is a prominent researcher. Fluent in Turkish, English, and basic German, they are known for their honesty, hard work, optimism, and foresight. 🌟📚🩺🌍

Experience

From 2011 to 2014, courses such as Dyspnea and Edema, Approach to Chest Pain, Fever and Hyperthermia, and Leukopenia and Leukocytosis were taught in the spring, while Chronic Leukemia, Aplastic Anemia and Myelodysplasia, and Principles of Blood Transfusion were covered in the autumn. Rheumatology topics like Anamnesis, Physical Examination, and Laboratory Test Analysis were emphasized. Other subjects included Familial Mediterranean Fever, Behcet’s Disease, Chronic Pancreatitis, Liver Cirrhosis, Esophageal Diseases, Colon Polyps, Celiac Disease, Chronic Viral and Non-Viral Hepatitis, and Mesenteric Ischemia. 🩺📚✨

Presentations

Dr. Gulali Aktaş has presented several notable studies. At the 30th World Congress of Endourology in 2012, his team discussed “Warfarin intoxication induced bilateral renal hematoma” (📚🩸). He compared surgical techniques for pylonidal sinus surgery and explored sleep quality in IBS patients at the XVI Annual European Society of Surgery (🔪💤). In 2013, at the 50th ERA-EDTA Congress, he highlighted the effects of nocturnal blood pressure on hemodialysis patients’ nutrition (🌙🩺). His research on metabolic syndrome, presented at the 10th Metabolic Syndrome Symposium, investigated platelet volume, epicardial adipose tissue, and non-alcoholic hepatosteatosis (🩸📈). At the 51st ERA-EDTA Congress, he examined atrial conduction in hemodialysis patients (❤️🩺).

Research focus

G Aktas focuses on the use of hematological and biochemical markers as diagnostic and prognostic tools in various medical conditions. His research includes studies on the neutrophil-to-lymphocyte ratio as an indicator for diabetic control in type 2 diabetes mellitus and Hashimoto’s thyroiditis. He also explores the predictive value of the uric acid to HDL cholesterol ratio for metabolic syndrome and diabetes control, as well as novel inflammatory markers derived from hemogram parameters in irritable bowel syndrome and COVID-19. His work aims to improve diagnostic accuracy and patient outcomes. 🩸🔬📊

Publication top notes

Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus

Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto’s thyroiditis

Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus

Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis?

Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus

Diabetes control could through platelet-to-lymphocyte ratio in hemograms

Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters

Could red cell distribution width be a marker in Hashimoto’s thyroiditis?

Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men

Hematological predictors of novel Coronavirus infection